Perfectus Biomed Limited is delighted to announce that we have received follow on funding from investors Spark Impact and Midven. Having achieved the key milestones agreed as part of the original funding, further resources have been made available to the company to pursue our quality and commercial objectives.
Dr Samantha Westgate, CEO, said ‘ We are delighted to receive further support from our investors in order to accelerate our development. The money will be used to support a broadening of the product offer and the addition of new staff, which will both contribute to increased capacity. We have a high level of customer loyalty and repeat business and our continued growth necessitated further support at this point.
Spark Impact issued the following press release: